PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.01%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.42%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
0.44%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
-4.70%
Negative net income growth while MRVL stands at 6.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.35%
Negative EPS growth while MRVL is at 10.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.35%
Negative diluted EPS growth while MRVL is at 22.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.46%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.54%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.15%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
-61.47%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-64.74%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
62.88%
10Y revenue/share CAGR under 50% of MRVL's 321.76%. Michael Burry would suspect a lasting competitive disadvantage.
68.66%
5Y revenue/share CAGR above 1.5x MRVL's 9.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
-5.06%
Negative 3Y CAGR while MRVL stands at 9.55%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
88.46%
10Y OCF/share CAGR at 75-90% of MRVL's 106.51%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
117.10%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
-3.34%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
112.73%
Below 50% of MRVL's 1080.29%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
3278.82%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
-21.06%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
40.88%
Below 50% of MRVL's 114.83%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
36.00%
5Y equity/share CAGR at 75-90% of MRVL's 47.29%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
8.43%
Below 50% of MRVL's 18.20%. Michael Burry suspects a serious short-term disadvantage in building book value.
1308.17%
Dividend/share CAGR of 1308.17% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
171.86%
Dividend/share CAGR of 171.86% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
129.32%
3Y dividend/share CAGR of 129.32% while MRVL is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.64%
AR growth well above MRVL's 12.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.98%
Inventory is declining while MRVL stands at 8.08%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.02%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.28%
We have a declining book value while MRVL shows 1.62%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
9.58%
Debt growth of 9.58% while MRVL is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
5.78%
R&D growth drastically higher vs. MRVL's 1.96%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.90%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.